Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

NCT00854581 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Investigator Decision

Conditions

Lymphoma
Precancerous/Nonmalignant Condition

Interventions

BIOLOGICAL: PEG-interferon alfa-2b
BIOLOGICAL: Interferon alfa-2b
DRUG: Valproic Acid
DRUG: Zidovudine

Sponsor

University of Miami

Collaborators

[object Object]